Patents Assigned to HALBERD CORPORATION
  • Treatment method for Cockayne syndrome
    Patent number: 11186629
    Abstract: Disclosed is a method for treating of Cockayne Syndrome (CS). Specifically, the invention pertains to a method for the extracorporeal treatment of a body fluid by removing the body fluid from a living body diseased with CS, and applying a targeted antibody either a mammalian target of rapamycin (mTOR) antigen or a death-associated protein 1 (DAP1) in a bodily fluid such as blood, creating an antibody-antigen complex, removing antibody-antigen complex from the bodily fluid, and returning the purified bodily fluid to the CS patient.
    Type: Grant
    Filed: February 5, 2020
    Date of Patent: November 30, 2021
    Assignee: HALBERD CORPORATION
    Inventor: Mitchell S. Felder